Search research articles
Contact Us
Filters
Showing results (71-80 of 220) with videos related to
Page
of 22
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patients
M A Graham, D R Newell, B J Foster, et al.
The Ulster Medical Journal
|
February 8, 2000
Laparoscopic cholecystectomy: experience with 303 patients over the initial four years
S Dolan, Z Khan, D McNally, et al.
British Journal of Clinical Pharmacology
|
December 1, 1983
The clinical pharmacology of chlorambucil and prednimustine
D R Newell, A H Calvert, K R Harrap, et al.
Journal - Association of Official Analytical Chemists
|
September 1, 1979
Aflatoxin variation among corn samples with varying ratios of Aspergillus flavus-inoculated/noninoculated kernels
E B Lillehoj, O H Calvert, W F Kwolek, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1984
Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics
A L Jackman, A H Calvert, L I Hart, et al.
Biochemical Pharmacology
|
October 15, 1984
Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717
A L Jackman, G A Taylor, A H Calvert, et al.
Journal of Sports Sciences
|
August 1, 1997
Identifying home advantage in international tennis and golf tournaments
A M Nevill, R L Holder, A Bardsley, et al.
Nature Medicine
|
August 1, 1996
Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer
I Sigalas, A H Calvert, J J Anderson, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1989
Estimation of the in vitro and in vivo inhibitory effects of antifolates upon thymidylate synthase (TS) in whole cells
G A Taylor, A L Jackman, K Balmanno, et al.
Lancet (London, England)
|
March 12, 1983
JMS, successor to cisplatin in advanced ovarian carcinoma?
E Wiltshaw, B D Evans, A C Jones, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 220) with videos related to
Sort By:
Page
of 22
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patients
M A Graham, D R Newell, B J Foster, et al.
The Ulster Medical Journal
|
February 8, 2000
Laparoscopic cholecystectomy: experience with 303 patients over the initial four years
S Dolan, Z Khan, D McNally, et al.
British Journal of Clinical Pharmacology
|
December 1, 1983
The clinical pharmacology of chlorambucil and prednimustine
D R Newell, A H Calvert, K R Harrap, et al.
Journal - Association of Official Analytical Chemists
|
September 1, 1979
Aflatoxin variation among corn samples with varying ratios of Aspergillus flavus-inoculated/noninoculated kernels
E B Lillehoj, O H Calvert, W F Kwolek, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1984
Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics
A L Jackman, A H Calvert, L I Hart, et al.
Biochemical Pharmacology
|
October 15, 1984
Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717
A L Jackman, G A Taylor, A H Calvert, et al.
Journal of Sports Sciences
|
August 1, 1997
Identifying home advantage in international tennis and golf tournaments
A M Nevill, R L Holder, A Bardsley, et al.
Nature Medicine
|
August 1, 1996
Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer
I Sigalas, A H Calvert, J J Anderson, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1989
Estimation of the in vitro and in vivo inhibitory effects of antifolates upon thymidylate synthase (TS) in whole cells
G A Taylor, A L Jackman, K Balmanno, et al.
Lancet (London, England)
|
March 12, 1983
JMS, successor to cisplatin in advanced ovarian carcinoma?
E Wiltshaw, B D Evans, A C Jones, et al.
Page
of 22